Complete Filing Data
Prime Medicine, Inc. reported Stockholders Equity of $120.87 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Prime Medicine, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$201.1M | -$195.9M | -$198.1M | -$121.8M | -$165.4M | -$3.4M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $81.0K | $16.0K | $369.0K | -$357.0K | -$27.0K | $0.00 |
| Other Nonoperating Income Expense | $148.0K | $41.0K | $274.0K | $1.9M | $12.0K | $126.0K |
| Operating Income Loss | -$208.4M | -$202.5M | -$204.8M | -$116.5M | -$84.5M | -$932.0K |
| Operating Expenses | $213.0M | $205.5M | $204.8M | $116.5M | $84.5M | $6.1M |
| Nonoperating Income Expense | $7.2M | $6.6M | $6.4M | -$6.2M | -$81.4M | -$611.0K |
| Net Income Loss Available To Common Stockholders Diluted | -$201.1M | -$195.9M | -$198.1M | -$142.0M | -$184.1M | -$5.1M |
| Net Income Loss Available To Common Stockholders Basic | -$201.1M | -$195.9M | -$198.1M | -$142.0M | -$184.1M | -$5.1M |
| General And Administrative Expense | $52.3M | $50.2M | $43.4M | $29.8M | $13.9M | $3.2M |
| Comprehensive Income Net Of Tax | -$201.1M | -$195.9M | -$197.8M | -$122.2M | -$165.4M | -$3.4M |
| Income Tax Expense Benefit | $0.00 | -$279.0K | -$948.0K | -$486.0K | $1.9M | |
| Research And Development Expense | $160.6M | $155.3M | $147.9M | $86.7M | $70.6M | $3.0M |
| Revenue From Contract With Customer Excluding Assessed Tax | $4.6M | $3.0M | $0.00 | $0.00 | $0.00 | $5.2M |
| Deferred Income Tax Expense Benefit | $0.00 | -$279.0K | -$964.0K | -$624.0K | $1.9M | |
| Research And Development Funding Liability Noncurrent | $18.0M | $6.0M | $0.00 | |||
| Deferred Income Tax Liabilities Net | $279.0K | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$50.6M | -$52.6M | -$51.9M | -$52.5M | -$55.3M | -$45.8M | -$50.7M | -$42.4M | -$39.4M | -$29.4M | -$29.3M | -$23.8M | -$16.4M | $616.0K | -$86.7M | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $43.0K | $5.0K | -$16.0K | $92.0K | $24.0K | -$80.0K | $119.0K | -$63.0K | $179.0K | -$304.0K | -$118.0K | -$5.0K | $25.0K | -$34.0K | ||
| Other Nonoperating Income Expense | $44.0K | $18.0K | $37.0K | -$83.0K | $39.0K | $42.0K | $43.0K | $41.0K | $2.1M | $728.0K | $238.0K | $11.0K | -$1.0K | |||
| Operating Income Loss | -$54.0M | -$53.4M | -$52.4M | -$54.2M | -$55.7M | -$48.3M | -$51.5M | -$45.3M | -$40.0M | -$31.7M | -$26.3M | -$19.9M | -$10.4M | |||
| Operating Expenses | $55.2M | $54.5M | $53.8M | $54.4M | $55.7M | $48.9M | $51.5M | $45.3M | $40.0M | $31.7M | $26.3M | $19.9M | $10.4M | |||
| Nonoperating Income Expense | $3.4M | $786.0K | $502.0K | $1.7M | $211.0K | $2.7M | $643.0K | $2.9M | $434.0K | $2.5M | -$3.5M | -$4.5M | -$8.4M | |||
| Net Income Loss Available To Common Stockholders Diluted | -$50.6M | -$52.6M | -$51.9M | -$52.5M | -$55.3M | -$45.8M | -$50.7M | -$42.4M | -$39.4M | -$35.7M | -$35.6M | -$30.1M | -$22.8M | |||
| Net Income Loss Available To Common Stockholders Basic | -$50.6M | -$52.6M | -$51.9M | -$52.5M | -$55.3M | -$45.8M | -$50.7M | -$42.4M | -$39.4M | -$35.7M | -$35.6M | -$30.1M | -$22.8M | |||
| General And Administrative Expense | $11.2M | $13.1M | $13.3M | $14.1M | $12.6M | $11.2M | $10.5M | $10.7M | $9.2M | $6.6M | $7.4M | $6.2M | $3.0M | |||
| Comprehensive Income Net Of Tax | -$50.5M | -$52.6M | -$51.9M | -$52.4M | -$55.3M | -$45.8M | -$50.6M | -$42.4M | -$39.2M | -$29.7M | -$29.5M | -$23.8M | -$16.4M | |||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$134.0K | $134.0K | -$108.0K | $31.0K | -$202.0K | $212.0K | -$442.0K | -$532.0K | -$2.4M | ||||
| Research And Development Expense | $44.0M | $41.4M | $40.6M | $40.3M | $43.1M | $37.8M | $41.0M | $34.6M | $30.9M | $25.0M | $13.7M | $7.4M | ||||
| Revenue From Contract With Customer Excluding Assessed Tax | $1.2M | $1.1M | $1.5M | $209.0K | $0.00 | $591.0K | $0.00 | $0.00 | $0.00 | |||||||
| Deferred Income Tax Expense Benefit | $0.00 | $134.0K | -$202.0K | -$532.0K | ||||||||||||
| Research And Development Funding Liability Noncurrent | $18.0M | $12.0M | $12.0M | $6.0M | $6.0M | $6.0M | ||||||||||
| Deferred Income Tax Liabilities Net | $134.0K | $0.00 | $0.00 | $108.0K | $77.0K | $481.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $120.9M | $153.1M | $133.1M | $316.3M | -$156.2M | $2.3M | -$2.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $76.7M | $196.5M | $55.1M | $201.1M | $198.5M | $37.0M | $8.6M |
| Cash And Cash Equivalents At Carrying Value | $63.0M | $182.5M | $41.6M | $187.6M | $185.4M | $37.0M | |
| Accretion Amortization Of Discounts And Premiums Investments | $2.5M | $3.5M | $5.7M | $250.0K | -$715.0K | $0.00 | |
| Restricted Cash | $13.7M | $14.1M | $13.5M | $13.5M | $13.1M | $0.00 | |
| Operating Lease Right Of Use Asset Amortization Expense | $9.7M | $12.4M | $12.8M | $9.8M | $4.3M | $0.00 | |
| Operating Lease Right Of Use Asset | $126.2M | $47.2M | $13.9M | $29.5M | $10.7M | $2.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$119.8M | $141.5M | -$146.0M | $2.6M | $161.6M | $28.3M | |
| Retained Earnings Accumulated Deficit | -$888.4M | -$687.2M | -$491.3M | -$293.2M | -$171.4M | ||
| Restricted Cash Noncurrent | $13.7M | $14.1M | $13.5M | $13.5M | $13.1M | ||
| Property Plant And Equipment Net | $20.6M | $24.4M | $22.7M | $19.0M | $4.9M | ||
| Operating Lease Liability Noncurrent | $108.3M | $37.2M | $4.4M | $17.1M | $3.1M | ||
| Operating Lease Liability Current | $8.1M | $3.6M | $9.3M | $11.7M | $7.3M | ||
| Liabilities Current | $37.4M | $38.0M | $56.4M | $26.7M | $58.0M | ||
| Liabilities And Stockholders Equity | $342.7M | $297.5M | $193.9M | $360.3M | $301.9M | ||
| Liabilities | $221.9M | $144.4M | $60.8M | $44.0M | $62.3M | ||
| Common Stock Value | $2.0K | $2.0K | $2.0K | $2.0K | $0.00 | ||
| Assets Current | $181.3M | $211.9M | $143.0M | $296.6M | $270.6M | ||
| Assets | $342.7M | $297.5M | $193.9M | $360.3M | $301.9M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $82.0K | $1.0K | -$15.0K | -$384.0K | -$27.0K | ||
| Accounts Payable Current | $8.9M | $11.4M | $19.5M | $4.3M | $1.4M | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $83.8M | $44.9M | $3.3M | $28.6M | $12.3M | $0.00 | |
| Accrued Liabilities Current | $12.6M | $15.9M | $14.1M | $10.7M | $37.2M | ||
| Other Assets Noncurrent | $1.0M | $0.00 | $779.0K | $1.6M | $2.5M | ||
| Preferred Stock Dividends Income Statement Impact | $0.00 | $20.2M | $17.3M | $0.00 | |||
| Other Assets Current | $674.0K | $14.7M | $2.3M | $246.0K | |||
| Decrease In Right Of Use Asset Due To Lease Termination | $3.1M | $0.00 | $6.1M | $0.00 | |||
| Accretion Amortization Of Discounts And Premiums Short Term Investments | $1.9M | $3.1M | $3.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $161.8M | $60.9M | $106.9M | $189.5M | $196.6M | $243.8M | $194.0M | $240.1M | $278.8M | -$223.1M | -$195.1M | -$166.9M | -$94.4M | -$78.4M | -$85.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $85.1M | $67.5M | $105.9M | $132.0M | $69.1M | $107.7M | $57.5M | $134.1M | $147.0M | $61.4M | $105.7M | $177.4M | $200.7M | ||
| Cash And Cash Equivalents At Carrying Value | $71.4M | $53.8M | $91.9M | $118.0M | $55.6M | $94.2M | $44.0M | $120.6M | $133.5M | $47.9M | $92.2M | $164.2M | $200.7M | ||
| Accretion Amortization Of Discounts And Premiums Investments | $752.0K | $530.0K | $339.0K | $885.0K | $1.5M | $830.0K | $1.8M | $2.0M | $611.0K | -$193.0K | |||||
| Restricted Cash | $13.7M | $13.7M | $14.1M | $14.1M | $13.5M | $13.5M | $13.5M | $13.5M | $13.5M | $13.5M | $13.5M | $13.1M | $0.00 | ||
| Operating Lease Right Of Use Asset Amortization Expense | $2.4M | $3.3M | $2.8M | $1.8M | |||||||||||
| Operating Lease Right Of Use Asset | $117.9M | $120.2M | $125.4M | $49.4M | $51.6M | $55.5M | $17.3M | $26.5M | $26.7M | $32.3M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$90.6M | $52.6M | -$54.2M | -$21.2M | |||||||||||
| Retained Earnings Accumulated Deficit | -$842.3M | -$791.7M | -$739.1M | -$644.9M | -$592.4M | -$537.1M | -$425.7M | -$375.0M | -$332.6M | -$253.9M | |||||
| Restricted Cash Noncurrent | $13.7M | $13.7M | $14.1M | $14.1M | $13.5M | $13.5M | $13.5M | $13.5M | $13.5M | $13.5M | |||||
| Property Plant And Equipment Net | $22.0M | $23.8M | $25.0M | $23.3M | $23.8M | $23.9M | $22.0M | $20.6M | $21.6M | $15.0M | |||||
| Operating Lease Liability Noncurrent | $110.4M | $112.5M | $114.3M | $36.8M | $36.4M | $37.0M | $5.8M | $11.9M | $14.2M | $19.9M | |||||
| Operating Lease Liability Current | $7.7M | $7.3M | $6.9M | $4.5M | $5.2M | $6.8M | $11.2M | $13.5M | $11.8M | $11.6M | |||||
| Liabilities Current | $35.0M | $34.1M | $34.3M | $37.9M | $20.7M | $24.4M | $39.4M | $28.7M | $23.9M | $22.2M | |||||
| Liabilities And Stockholders Equity | $385.0M | $279.0M | $328.2M | $332.8M | $259.7M | $311.4M | $239.1M | $280.9M | $316.9M | $215.3M | |||||
| Liabilities | $223.2M | $218.1M | $221.2M | $143.3M | $63.1M | $67.6M | $45.2M | $40.8M | $38.1M | $42.6M | |||||
| Common Stock Value | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $0.00 | |||||
| Assets Current | $231.4M | $121.3M | $163.8M | $246.1M | $170.8M | $217.7M | $184.5M | $218.5M | $253.5M | $148.8M | |||||
| Assets | $385.0M | $279.0M | $328.2M | $332.8M | $259.7M | $311.4M | $239.1M | $280.9M | $316.9M | $215.3M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $33.0K | -$10.0K | -$15.0K | $21.0K | -$71.0K | -$95.0K | -$149.0K | -$268.0K | -$205.0K | -$454.0K | |||||
| Accounts Payable Current | $9.4M | $6.4M | $10.0M | $5.4M | $4.6M | $10.1M | $14.1M | $5.5M | $4.6M | $4.1M | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $83.8M | $44.9M | $0.00 | ||||||||||||
| Accrued Liabilities Current | $11.0M | $12.2M | $9.2M | $18.7M | $10.9M | $7.6M | $14.0M | $7.5M | $6.5M | ||||||
| Other Assets Noncurrent | $0.00 | $0.00 | $779.0K | $1.8M | $1.8M | $1.6M | $5.6M | ||||||||
| Preferred Stock Dividends Income Statement Impact | $0.00 | $0.00 | $0.00 | $6.4M | $6.3M | $6.2M | $6.4M | ||||||||
| Other Assets Current | $15.6M | $16.4M | $16.5M | $9.5M | $3.7M | $2.7M | |||||||||
| Decrease In Right Of Use Asset Due To Lease Termination | $3.1M | $0.00 | |||||||||||||
| Accretion Amortization Of Discounts And Premiums Short Term Investments | $164.0K | $675.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $29.3M | $26.1M | $13.9M | $6.5M | $1.7M | $391.0K |
| Depreciation Depletion And Amortization | $7.3M | $6.1M | $4.7M | $2.2M | $568.0K | $43.0K |
| Increase Decrease In Operating Lease Liability | -$5.4M | -$6.5M | -$12.3M | -$10.2M | -$4.3M | $0.00 |
| Share Based Compensation | $29.3M | $26.1M | $13.9M | $6.5M | $1.7M | $391.0K |
| Proceeds From Stock Options Exercised | $781.0K | $103.0K | $655.0K | $219.0K | $0.00 | $0.00 |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $95.8M | $204.2M | $132.6M | $93.0M | $13.0M | $0.00 |
| Payments To Acquire Short Term Investments | $205.4M | $129.4M | $105.0M | $123.3M | $82.0M | $0.00 |
| Payments To Acquire Property Plant And Equipment | $4.5M | $7.3M | $8.7M | $16.1M | $4.2M | $639.0K |
| Net Cash Provided By Used In Operating Activities | -$162.6M | -$122.9M | -$165.4M | -$131.8M | -$34.1M | -$5.5M |
| Net Cash Provided By Used In Investing Activities | -$108.8M | $68.5M | $18.7M | -$47.1M | -$73.6M | -$1.1M |
| Net Cash Provided By Used In Financing Activities | $151.5M | $195.9M | $655.0K | $181.5M | $269.3M | $34.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$4.5M | $15.9M | $9.5M | $1.7M | $885.0K | $388.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.2M | $1.8M | $1.8M | -$25.9M | $35.2M | $302.0K |
| Increase Decrease In Accounts Payable | $996.0K | -$5.3M | $9.1M | $2.5M | $1.2M | $250.0K |
| Increase Decrease In Equity Securities Fv Ni | $432.0K | -$484.0K | -$2.4M | -$8.1M | ||
| Payments For Security Deposits | $170.0K | $665.0K | $496.0K | $423.0K | ||
| Increase Decrease In Accrued Settlement Payment | $0.00 | -$13.5M | $13.5M | $0.00 | ||
| Proceeds From Research And Development Funding Liability | $12.0M | $6.0M | $0.00 | |||
| Proceeds From Issuance Of Warrants | $0.00 | $18.8M | $0.00 | |||
| Proceeds From Issuance Follow On Offering | $138.4M | $132.1M | $0.00 | |||
| Proceeds From ESPP Offerings | $341.0K | $837.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $12.7M | $6.3M | $5.7M | $6.8M | $8.1M | $5.2M | $4.2M | $3.6M | $1.7M | $1.4M | $1.3M | $1.1M | $339.0K | $94.0K | $206.0K |
| Depreciation Depletion And Amortization | $1.9M | $1.9M | $1.7M | $1.6M | $1.5M | $1.3M | $1.2M | $1.1M | $1.1M | $631.0K | $430.0K | $293.0K | $200.0K | ||
| Increase Decrease In Operating Lease Liability | -$638.0K | -$3.5M | -$2.8M | -$2.3M | |||||||||||
| Share Based Compensation | $5.7M | $5.2M | $1.7M | $1.1M | |||||||||||
| Proceeds From Stock Options Exercised | $0.00 | $36.0K | $68.0K | $0.00 | |||||||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $3.0M | $72.5M | $35.0M | $32.5M | |||||||||||
| Payments To Acquire Short Term Investments | $48.3M | $107.2M | $45.7M | $0.00 | |||||||||||
| Payments To Acquire Property Plant And Equipment | $2.4M | $2.3M | $2.0M | $1.7M | |||||||||||
| Net Cash Provided By Used In Operating Activities | -$48.9M | -$67.7M | -$41.6M | -$50.8M | |||||||||||
| Net Cash Provided By Used In Investing Activities | -$47.7M | -$37.0M | -$12.7M | $30.9M | |||||||||||
| Net Cash Provided By Used In Financing Activities | $6.0M | $157.3M | $68.0K | -$1.3M | |||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $789.0K | $2.8M | $1.3M | -$292.0K | |||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$6.7M | -$4.5M | -$4.0M | -$33.3M | |||||||||||
| Increase Decrease In Accounts Payable | $1.9M | -$5.9M | -$504.0K | $1.0M | |||||||||||
| Increase Decrease In Equity Securities Fv Ni | -$1.1M | $1.2M | -$1.7M | ||||||||||||
| Payments For Security Deposits | $0.00 | -$81.0K | |||||||||||||
| Increase Decrease In Accrued Settlement Payment | $0.00 | -$13.5M | $0.00 | ||||||||||||
| Proceeds From Research And Development Funding Liability | $6.0M | $6.0M | $0.00 | ||||||||||||
| Proceeds From Issuance Of Warrants | $0.00 | $18.8M | $0.00 | ||||||||||||
| Proceeds From Issuance Follow On Offering | $0.00 | $132.1M | $0.00 | ||||||||||||
| Proceeds From ESPP Offerings | $0.00 | $436.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 148.8M | 118.6M | 91.0M | 33.9M | 13.0M | 2.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 148.8M | 118.6M | 91.0M | 33.9M | 13.0M | 2.6M |
| Earnings Per Share Diluted | $-1.35 | $-1.65 | $-2.18 | $-4.19 | $-14.19 | $-1.91 |
| Earnings Per Share Basic | $-1.35 | $-1.65 | $-2.18 | $-4.19 | $-14.19 | $-1.91 |
| Common Stock Shares Outstanding | 180.5M | 131.2M | 97.4M | 97.2M | 32.4M | |
| Common Stock Shares Issued | 180.5M | 131.2M | 97.4M | 97.2M | 32.4M | |
| Common Stock Shares Authorized | 775.0M | 775.0M | 775.0M | 775.0M | 293.3M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 160.5M | 129.2M | 130.9M | 119.8M | 119.2M | 104.5M | 91.8M | 90.5M | 89.1M | 22.2M | 20.2M | 19.1M | 15.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 160.5M | 129.2M | 130.9M | 119.8M | 119.2M | 104.5M | 91.8M | 90.5M | 89.1M | 22.2M | 20.2M | 19.1M | 15.0M |
| Earnings Per Share Diluted | $-0.32 | $-0.41 | $-0.40 | $-0.44 | $-0.46 | $-0.44 | $-0.55 | $-0.47 | $-0.44 | $-1.61 | $-1.76 | $-1.58 | $-1.52 |
| Earnings Per Share Basic | $-0.32 | $-0.41 | $-0.40 | $-0.44 | $-0.46 | $-0.44 | $-0.55 | $-0.47 | $-0.44 | $-1.61 | $-1.76 | $-1.58 | $-1.52 |
| Common Stock Shares Outstanding | 180.3M | 134.5M | 131.2M | 131.2M | 120.0M | 120.0M | 97.3M | 97.3M | 97.2M | 33.6M | |||
| Common Stock Shares Issued | 180.3M | 134.5M | 131.2M | 131.2M | 120.0M | 120.0M | 97.3M | 97.3M | 97.2M | 33.6M | |||
| Common Stock Shares Authorized | 775.0M | 775.0M | 775.0M | 775.0M | 775.0M | 775.0M | 775.0M | 775.0M | 775.0M | 293.3M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Income Loss Attributable To Parent | -$195.9M | -$198.4M | -$122.8M | -$165.9M | -$1.5M | |
| Stock Issued During Period Value Stock Options Exercised | $781.0K | $103.0K | $655.0K | $219.0K | ||
| Change In Fair Value Of Short Term Investment | $432.0K | -$485.0K | -$2.4M | -$8.1M | ||
| Capital Expenditures Incurred But Not Yet Paid | $114.0K | $1.2M | $575.0K | $969.0K | $754.0K | $0.00 |
| Additional Paid In Capital | $1.01B | $840.4M | $624.4M | $609.8M | $15.2M | |
| Investment Income Interest | $4.1M | $3.5M | $2.8M | |||
| Prepaid Expense Current | $2.9M | $6.8M | $19.1M | $2.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Loss Attributable To Parent | -$52.6M | -$51.9M | -$52.5M | -$55.5M | -$45.6M | -$50.8M | -$42.4M | -$39.6M | -$29.1M | -$29.8M | -$24.4M | -$18.8M | |
| Stock Issued During Period Value Stock Options Exercised | $373.0K | $32.0K | $35.0K | $36.0K | $227.0K | $166.0K | $68.0K | $204.0K | |||||
| Change In Fair Value Of Short Term Investment | $1.5M | -$505.0K | -$1.1M | $215.0K | -$1.9M | $1.2M | -$1.6M | $263.0K | -$1.7M | $1.8M | -$3.7M | ||
| Capital Expenditures Incurred But Not Yet Paid | $985.0K | $833.0K | $2.6M | $1.1M | |||||||||
| Additional Paid In Capital | $1.00B | $852.6M | $846.0M | $834.4M | $789.1M | $781.0M | $619.8M | $615.3M | $611.6M | $31.3M | |||
| Investment Income Interest | $1.1M | $743.0K | $1.2M | $697.0K | $611.0K | $676.0K | $410.0K | $635.0K | |||||
| Prepaid Expense Current | $2.5M | $3.0M | $2.9M | $6.0M | $4.2M | $4.2M |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.